Transplant-ineligible 2nd Line DLBCL
1 clinical trials · Condition
◉ Watch Transplant-ineligible 2nd Line DLBCL
| Record | Firm | Date |
|---|---|---|
| DALY II USA/ MB-CART2019.1 for DLBCL (NCT04792489) | Miltenyi Biomedicine GmbH | 2021-05-25 |
Track Transplant-ineligible 2nd Line DLBCL automatically
Every clearance here is in the API, with alerts when new ones post.